RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Current status and future perspective of natural killer cell therapy for cancer.
Current status and future perspective of natural killer cell therapy for cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
自然杀伤(NK)细胞具有有效清除癌细胞的先天能力。然而,由于NK细胞在癌症治疗后增殖困难且易被诱导功能障碍,NK细胞输注的疗效受到限制,未能在临床实践中广泛应用。生物技术的快速发展推动了NK细胞疗法在癌症治疗中的发展。在这篇综述中,我们将全面分析NK细胞疗法治疗癌症的现状和未来前景,重点关注NK细胞的生物学特性,以及增强其靶向能力和克服微环境中肿瘤免疫抑制的策略。
Natural killer (NK) cells possess innate abilities to effectively eliminate cancer cells.
However, because of difficulties of proliferation and easy to be induced dysfunction in the setting of cancer post NK cell therapy, the curative effect of NK cell infusion has been constrained and not been widely applicable in clinical practice. The rapid development of biotechnology has promoted the development of NK cell therapy for cancer treatment.
In this review, we will provide a comprehensive analysis of the current status and future prospects of NK cell therapy for cancer, focusing on the biological characteristics of NK cells, as well as strategies to enhance their targeting capabilities and overcome tumor immune suppression within the microenvironment.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。